Tumor-Homing, Size-Tunable Clustered Nanoparticles for Anticancer Therapeutics
Source abstract
Abstract
We present herein a pH-responsive dynamic DNA nanocluster based on gold nanoparticles with highly packed nucleic acid assembly and evaluate its potential as a drug delivery vehicle with tumor-specific accumulation. Each gold nanoparticle was readily functionalized with various functional DNA sequences; in particular, we modified the surface of gold nanoparticles with bcl-2 antisense and i-motif binding sequences. Clustering of the gold nanoparticles induced by hybridization of each DNA sequence via i-motif DNA provided tumor targeting and drug loading capabilities. After cellular uptake, the drug was released by disassembly of the gold nanoparticle cluster into single gold nanoparticles in response to the pH decrease in the late endosome. Furthermore, the antiapoptotic Bcl-2 protein was down-regulated by the antisense-modified gold nanoparticles; thus, drug-mediated apoptosis was significantly accelerated by sensitizing the cancer cells to the drug. Our size-tunable clustered nucleic acid-grafted gold nanoparticles provide tumor homing in the blood circulation and are thus a potential multifunctional therapeutic agent in vivo as well as in vitro.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Self-assembly and Complexity, Institute for Basic Science (IBS), Pohang 790-784, Korea
Department of Chemistry Polymer Research Institute, Pohang University of Science and Technology (POSTECH), Pohang 790-784, Korea
Funding
Institute for Basic Science
References (46)
Show source-provided references
1. Cho K. J. · Clin. Cancer Res. · 2008 · 14 · 131010.1158/1078-0432.CCR-07-1441 ↗
2. Huang K. Y. · ACS Nano · 2012 · 6 · 448310.1021/nn301282m ↗
3. Maeda H. · Adv. Drug Delivery Rev. · 2013 · 65 · 7110.1016/j.addr.2012.10.002 ↗
4. Albanese A. · Annu. Rev. Biomed. Eng. · 2012 · 14 · 110.1146/annurev-bioeng-071811-150124 ↗
5. De Jong W. H. · Biomaterials · 2008 · 29 · 191210.1016/j.biomaterials.2007.12.037 ↗
6. Kim J. · Biomaterials · 2013 · 34 · 716810.1016/j.biomaterials.2013.05.072 ↗
7. Kim H. · ACS Nano · 2013 · 7 · 673510.1021/nn403096s ↗
8. Cutler J. I. · J. Am. Chem. Soc. · 2012 · 134 · 137610.1021/ja209351u ↗
9. Giljohann D. A. · Angew. Chem., Int. Ed. · 2010 · 49 · 328010.1002/anie.200904359 ↗
10. Macfarlane R. J. · Angew. Chem., Int. Ed. · 2013 · 52 · 568810.1002/anie.201209336 ↗
11. Farokhzad O. C. · Adv. Drug Delivery Rev. · 2006 · 58 · 145610.1016/j.addr.2006.09.011 ↗
12. Rosi N. L. · Chem. Rev. · 2005 · 105 · 154710.1021/cr030067f ↗
13. Giljohann D. A. · Nano lett · 2007 · 7 · 381810.1021/nl072471q ↗
14. Giljohann D. A. · J. Am. Chem. Soc. · 2009 · 131 · 207210.1021/ja808719p ↗
15. Rosi N. L. · Science · 2006 · 312 · 102710.1126/science.1125559 ↗
16. Cutler J. I. · J. Am. Chem. Soc. · 2011 · 133 · 925410.1021/ja203375n ↗
17. Huo F. W. · Adv. Mater. · 2006 · 18 · 230410.1002/adma.200601178 ↗
18. Xu X. Y. · J. Am. Chem. Soc. · 2006 · 128 · 928610.1021/ja061980b ↗
19. Maye M. M. · Nat. Mater. · 2009 · 8 · 38810.1038/nmat2421 ↗
20. Lim D. K. · Nat. Mater. · 2010 · 9 · 6010.1038/nmat2596 ↗
21. Seferos D. S. · Nano Lett. · 2009 · 9 · 30810.1021/nl802958f ↗
22. Massich M. D. · Mol. Pharmaceutics · 2009 · 6 · 193410.1021/mp900172m ↗
23. Wu C. · J. Am. Chem. Soc. · 2013 · 135 · 1864410.1021/ja4094617 ↗
24. Zheng J. · ACS Nano · 2013 · 7 · 654510.1021/nn402344v ↗
25. Seeman N. C. · Biophys. J. · 1983 · 44 · 20110.1016/S0006-3495(83)84292-1 ↗
26. Yurke B. · Nature · 2000 · 406 · 60510.1038/35020524 ↗
27. Modi S. · Nat. Nanotechnol. · 2009 · 4 · 32510.1038/nnano.2009.83 ↗
28. Scheinberg D. A. · Nat. Rev. Clin. Oncol. · 2010 · 7 · 26610.1038/nrclinonc.2010.38 ↗
29. Surana S. · Nat. Commun. · 2011 · 2 · 34010.1038/ncomms1340 ↗
30. Bagalkot V. · Angew. Chem., Int. Ed. · 2006 · 45 · 814910.1002/anie.200602251 ↗
31. Kim D. · ACS Nano · 2010 · 4 · 368910.1021/nn901877h ↗
32. Xiao Z. Y. · Angew. Chem., Int. Ed. · 2012 · 51 · 1185310.1002/anie.201204018 ↗
33. Chen A. M. · Small · 2009 · 5 · 267310.1002/smll.200900621 ↗
34. Hong X. · Int. J. Mol. Med. · 2011 · 28 · 953
35. Lage H. · Cell. Mol. Life Sci. · 2008 · 65 · 314510.1007/s00018-008-8111-5 ↗
36. Wu L. L. · Biomaterials · 2013 · 34 · 526210.1016/j.biomaterials.2013.03.035 ↗
37. Meng F. H. · Nanomedicine · 2014 · 9 · 48710.2217/nnm.13.212 ↗
38. Son S. · ACS Nano · 2014 · 8 · 557410.1021/nn5022567 ↗
39. Gueron M. · Curr. Opin. Struct. Biol. · 2000 · 10 · 32610.1016/S0959-440X(00)00091-9 ↗
40. Sharma J. · Chem. Commun. · 2007 · 47710.1039/B612707J ↗
41. Jones M. R. · Nat. Mater. · 2010 · 9 · 91310.1038/nmat2870 ↗
42. Liu J. · Nat. Protoc. · 2006 · 1 · 24610.1038/nprot.2006.38 ↗
43. Macfarlane R. J. · Angew. Chem., Int. Ed. · 2010 · 49 · 458910.1002/anie.201000633 ↗
44. Choi C. H. · Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 762510.1073/pnas.1305804110 ↗
45. Jensen S. A. · Sci. Transl. Med. · 2013 · 5 · 20910.1126/scitranslmed.3006839 ↗
46. Zheng D. · Proc. Natl. Acad. Sci. U.S.A. · 2012 · 109 · 1197510.1073/pnas.1118425109 ↗